Clinical trial
Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative…
NCT00013689 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00013689 |
|---|---|
| Title | Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome |
| Official title | Pilot Study of Pyrimethamine and Sulfadoxine (Fansidar) for the Treatment of Individuals With the Autoimmune Lymphoproliferative Syndrome (ALPS) |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Autoimmune Disease, Lymphoproliferative Disorder |
| Intervention type | Drug |
| Interventions | Fansidar (pyrimethamine and sulfadoxine) |
| Enrollment | 8 |
| Start date | Mar 1, 2001 |
| Completion | Mar 1, 2003 |
| First posted | Mar 29, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: